A Trial to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients with COPD

Summary

To evaluate the efficacy and safety of HL231 Solution for Inhalation vs Ultibro in Chinese patients with moderate to severe COPD.

Timeline

Start

2022-01-12

Primary completion

2023-05-29

Completion

2023-05-29

Publications

• Hu Q, Zhao L, Yang G, Wen F, Xie L, Xiao Z, Chen F, He Q, Bian T, Xiong H, Li F, Yue Y, Li Y, Luo L, Luo Z. Efficacy, pharmacokinetics, and safety of nebulized HL231 inhalation solution in patients with chronic obstructive pulmonary disease: a randomized trial. J Thorac Dis. 2025 Oct 31;17(10):7459-7472. doi: 10.21037/jtd-2025-1130. Epub 2025 Oct 9.

Drugs

Indications